Claudin 4 Protein-VLP (CLDN4) (AA 1-209)
Quick Overview for Claudin 4 Protein-VLP (CLDN4) (AA 1-209) (ABIN7504302)
Target
See all Claudin 4 (CLDN4) ProteinsProtein Type
Origin
Source
Purity
-
-
Protein Characteristics
- AA 1-209
-
Purpose
- Human Claudin 4 Protein-VLP
-
Sequence
- Met1-Val209
-
Characteristics
- Recombinant Human Claudin 4 Protein-VLP is expressed from HEK293.It contains Met1-Val209.
-
Sterility
- 0.22 μm filtered
-
Endotoxin Level
- Less than 1EU per μg by the LAL method.
-
-
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!ProductExpression SystemConjugateOriginPrice starts atExpression System HEK-293 CellsConjugate His tagOrigin HumanPrice starts at $16,231.82Expression System Cell-free protein synthesis (CFPS)Conjugate Strep TagOrigin HumanPrice starts at $15,754.29Your project requires further customization? Contact us and discover our custom protein solutions
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Supplied as 0.22μm filtered solution in PBS, 300 mM L-Arginine ( pH 7.4).
Notice: If you need it for immunization, Do Not use any adjuvant. -
Storage
- -80 °C
-
Storage Comment
- Valid for 12 months from date of receipt when stored at -80°C.,Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- Claudin 4 (CLDN4)
-
Alternative Name
- Claudin 4
-
Background
- Claudin-4 (CLDN4) is a key component of tight junctions (TJs) in epithelial cells. CLDN4 is overexpressed in many epithelial malignancies and correlates with cancer progression. Changes in CLDN4 expression have been associated with epigenetic factors (such as hypomethylation of promoter DNA), inflammation associated with infection and cytokines, and growth factor signaling. CLDN4 helps to maintain the tumor microenvironment by forming TJs and acts as a barrier to the entry of anticancer drugs into tumors.
-
Molecular Weight
- 23.31 kDa.
-
UniProt
- O14493
-
Pathways
- Hepatitis C
Target
-